Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Marian MOKAN"'
Autor:
Matej Samoš, Ingrid Škorňová, Tomáš Bolek, Lucia Stančiaková, Barbora Korpallová, Peter Galajda, Ján Staško, Peter Kubisz, Marián Mokáň
Publikováno v:
Diagnostics, Vol 11, Iss 1, p 143 (2021)
Platelets play crucial role in acute vascular atherosclerotic diseases, including myocardial infarction and stroke. Additionally, platelet aggregation is a key target of antiplatelet agents, forming the keystone of pharmacotherapy of various atherosc
Externí odkaz:
https://doaj.org/article/32c16b71f4a84d06983c2229c742443b
Autor:
Ingrid Skornova, Tomas Simurda, Lucia Stanciakova, Viliam Lauko, Pavol Holly, Matej Samos, Tomas Bolek, Martin Schnierer, Miroslava Drotarova, Kristina Maria Belakova, Juraj Sokol, Jan Stasko, Marian Mokan, Jaroslav Gumulec, Leona Chrastinova
Publikováno v:
Diagnostics, Vol 13, Iss 18, p 3019 (2023)
Heparin-induced thrombocytopenia (HIT) is a life-threatening complication of heparin therapy (both unfractionated heparin and low-molecular-weight heparin). In our study, we examined a group of 122 patients with suspected HIT. The samples of all pati
Externí odkaz:
https://doaj.org/article/e998bf12e7e04cfa945152c1b65dbb09
Autor:
Renata Michalova, Anna Mankova, Matej Vnucak, Stanislava Mikulova, Frantisek Nehaj, Katarina Raslova, Ivana Dedinska, Alena Jezikova, Pavel Makovicky, Peter Galajda, Marian Mokan
Publikováno v:
Biomedical Papers, Vol 163, Iss 1, Pp 90-94 (2019)
Introduction: Hormone changes during pregnancy lead to increased plasma lipid levels. When there is added disorder of lipid metabolism, this otherwise physiological change can cause extremely high triglyceride levels with potentionally life-threateni
Externí odkaz:
https://doaj.org/article/74606004967646d197eb35f29d5e7918
Autor:
Juraj Sokol MD, PhD, Frantisek Nehaj MD, Jela Ivankova RNDr, Michal Mokan MD, PhD, Jana Zolkova RNDr, Lenka Lisa MD, PhD, Ludmila Linekova MD, Marian Mokan MD, DSc, FRCP Edin, Jan Stasko MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
A rapid and reliable assessment of the dabigatran effect is desirable in dabigatran treated patients with uncontrolled bleeding or before acute surgery. The aim of this study was to study the anticoagulant effects of dabigatran in patients with atria
Externí odkaz:
https://doaj.org/article/45ffc6ca78f2438e8496473c24f36106
Autor:
Juraj Sokol MD, PhD, Frantisek Nehaj MD, Jela Ivankova RNDr, Michal Mokan MD, PhD, Lenka Lisa MD, PhD, Jana Zolkova RNDr, Lubica Vadelova RNDr, Marian Mokan Prof, MD, DSc, FRCP Edin, Jan Stasko Prof, MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Edoxaban, a direct factor Xa inhibitor (FXa), is the fourth direct oral anticoagulant (DOAC) approved for clinical use. As the main adverse event is bleeding, it is relevant whether edoxaban has additional effects on platelet function. We aimed to as
Externí odkaz:
https://doaj.org/article/90ee2f85093240908bd3f4c5594d9b6e
Autor:
Marta Ondrejkova, Peter Jackuliak, Emil Martinka, Marian Mokan, James Foley, Jana Fabkova, Karol Gecik, Iveta Tvrda, Miroslav Helbich, Monika Gajdosova, DIARET SK study group
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0223788 (2019)
PURPOSE:To evaluate the prevalence and epidemiological characteristics of diabetic retinopathy (DR) in Slovakian patients with Type 1 and 2 diabetes mellitus (DM) in the DIARET SK study. PATIENTS AND METHODS:An epidemiological multi-center survey tha
Externí odkaz:
https://doaj.org/article/a4572a5abb08437a9ac6715151c730ad
Autor:
Daniela Stanikova, Marek Buzga, Patrik Krumpolec, Martina Skopkova, Martina Surova, Barbara Ukropcova, Lubica Ticha, Miroslava Petrasova, Dominika Gabcova, Miroslava Huckova, Lucie Piskorova, Jan Bozensky, Marian Mokan, Jozef Ukropec, Ivona Zavacka, Iwar Klimes, Juraj Stanik, Daniela Gasperikova
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177222 (2017)
BACKGROUND:Inactivating mutations of the hypothalamic transcription factor singleminded1 (SIM1) have been shown as a cause of early-onset severe obesity. However, to date, the contribution of SIM1 mutations to the obesity phenotype has only been stud
Externí odkaz:
https://doaj.org/article/c19e4cfce54d414c8a80a20dcd2a4f78
Autor:
Jakub BENKO, Miroslava SARLINOVA, Veronika MIKUSOVA, Tomas BOLEK, Martin Jozef PEC, Erika HALASOVA, Peter GALAJDA, Matej SAMOS, Marian MOKAN
Publikováno v:
Bratislava Medical Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b603b1ac2a209930051a42f1208359d5
https://doi.org/10.4149/bll_2023_081
https://doi.org/10.4149/bll_2023_081
Autor:
Jan Stasko, Lucia Stančiaková, Peter Galajda, Peter Kubisz, Marian Mokan, Kristína Grilusová, Matej Samoš, Veronika Mikušová, Ingrid Škorn ová, Tomáš Bolek
Publikováno v:
American Journal of Therapeutics. 29:e212-e218
Apixaban, a direct inhibitor of activated coagulation factor X (FXaI), is being frequently selected for treatment and prevention of venous thromboembolism (VTE). Several reports about possible use of oral FXaI in patients with cancer-associated VTE (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51b6389ab53c93625c8e7f38d189c771
https://doi.org/10.1097/mjt.0000000000001451
https://doi.org/10.1097/mjt.0000000000001451
Publikováno v:
Journal of Thrombosis and Thrombolysis. 49:578-583
Edoxaban is an oral anticoagulant drug and a direct factor Xa inhibitor. However, it is still not fully understood if and how edoxaban impacts platelet function. This prospective study aimed to assess in vitro platelet function in patients with atria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f49cf3583ecb40493611b6d7add8875f
https://doi.org/10.1007/s11239-020-02093-9
https://doi.org/10.1007/s11239-020-02093-9